Growth Metrics

Qiagen (QGEN) EBITDA Margin (2016 - 2025)

Qiagen's EBITDA Margin history spans 17 years, with the latest figure at 9.42% for Q4 2025.

  • On a quarterly basis, EBITDA Margin fell 73.0% to 9.42% in Q4 2025 year-over-year; TTM through Dec 2025 was 26.87%, a 1731.0% increase, with the full-year FY2025 number at 31.56%, up 1634.0% from a year prior.
  • EBITDA Margin hit 9.42% in Q4 2025 for Qiagen, down from 33.82% in the prior quarter.
  • Over the last five years, EBITDA Margin for QGEN hit a ceiling of 41.39% in Q1 2022 and a floor of 35.27% in Q2 2024.
  • Historically, EBITDA Margin has averaged 22.57% across 5 years, with a median of 30.85% in 2023.
  • Biggest five-year swings in EBITDA Margin: plummeted -6691bps in 2024 and later soared 6739bps in 2025.
  • Tracing QGEN's EBITDA Margin over 5 years: stood at 16.26% in 2021, then plummeted by -50bps to 8.1% in 2022, then increased by 3bps to 8.34% in 2023, then rose by 22bps to 10.15% in 2024, then fell by -7bps to 9.42% in 2025.
  • Business Quant data shows EBITDA Margin for QGEN at 9.42% in Q4 2025, 33.82% in Q3 2025, and 32.12% in Q2 2025.